Works matching IS 15228517 AND DT 2022 AND VI 24 AND IP 3

Results: 21
    1

    Forthcoming Meetings.

    Published in:
    Neuro-Oncology, 2022, v. 24, n. 3, p. 502, doi. 10.1093/neuonc/noac038
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9
    10

    Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline.

    Published in:
    Neuro-Oncology, 2022, v. 24, n. 3, p. 358, doi. 10.1093/neuonc/noab279
    By:
    • Mohile, Nimish A;
    • Messersmith, Hans;
    • Gatson, Na Tosha N;
    • Hottinger, Andreas F;
    • Lassman, Andrew B;
    • Morton, Jordan;
    • Ney, Douglas;
    • Nghiemphu, Phioanh Leia;
    • Olar, Adriana;
    • Olson, Jeffery;
    • Perry, James;
    • Portnow, Jana;
    • Schiff, David;
    • Shannon, Anne;
    • Shih, Helen A;
    • Strowd, Roy;
    • van den Bent, Martin;
    • Ziu, Mateo;
    • Blakeley, Jaishri
    Publication type:
    Article
    11
    12
    13

    Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline.

    Published in:
    Neuro-Oncology, 2022, v. 24, n. 3, p. 331, doi. 10.1093/neuonc/noab262
    By:
    • Vogelbaum, Michael A;
    • Brown, Paul D;
    • Messersmith, Hans;
    • Brastianos, Priscilla K;
    • Burri, Stuart;
    • Cahill, Dan;
    • Dunn, Ian F;
    • Gaspar, Laurie E;
    • Gatson, Na Tosha N;
    • Gondi, Vinai;
    • Jordan, Justin T;
    • Lassman, Andrew B;
    • Maues, Julia;
    • Mohile, Nimish;
    • Redjal, Navid;
    • Stevens, Glen;
    • Sulman, Erik;
    • van den Bent, Martin;
    • Wallace, H James;
    • Weinberg, Jeffrey S
    Publication type:
    Article
    14

    DNA methylation-based prognostic subtypes of chordoma tumors in tissue and plasma.

    Published in:
    Neuro-Oncology, 2022, v. 24, n. 3, p. 442, doi. 10.1093/neuonc/noab235
    By:
    • Zuccato, Jeffrey A;
    • Patil, Vikas;
    • Mansouri, Sheila;
    • Liu, Jeffrey C;
    • Nassiri, Farshad;
    • Mamatjan, Yasin;
    • Chakravarthy, Ankur;
    • Karimi, Shirin;
    • Almeida, Joao Paulo;
    • Bernat, Anne-Laure;
    • Hasen, Mohammed;
    • Singh, Olivia;
    • Khan, Shahbaz;
    • Kislinger, Thomas;
    • Sinha, Namita;
    • Froelich, Sébastien;
    • Adle-Biassette, Homa;
    • Aldape, Kenneth D;
    • Carvalho, Daniel D De;
    • Zadeh, Gelareh
    Publication type:
    Article
    15

    Body CT and PET/CT detection of extracranial lymphoma in patients with newly diagnosed central nervous system lymphoma.

    Published in:
    Neuro-Oncology, 2022, v. 24, n. 3, p. 482, doi. 10.1093/neuonc/noab234
    By:
    • Suh, Chong Hyun;
    • Kim, Ho Sung;
    • Ahn, Sung Soo;
    • Seong, Minjung;
    • Han, Kichang;
    • Park, Ji Eun;
    • Jung, Seung Chai;
    • Choi, Choong Gon;
    • Kim, Sang Joon;
    • Lee, Sang Min;
    • Kim, Jeong Hoon;
    • Lee, Seung-Koo;
    • Choi, Seung Hong;
    • Kim, Sung Tae;
    • Nayak, Lakshmi;
    • Batchelor, Tracy T;
    • Huang, Raymond Y;
    • Guenette, Jeffrey P
    Publication type:
    Article
    16

    EGFRvIII transcriptome in glioblastoma: A meta-omics analysis.

    Published in:
    Neuro-Oncology, 2022, v. 24, n. 3, p. 429, doi. 10.1093/neuonc/noab231
    By:
    • Hoogstrate, Youri;
    • Ghisai, Santoesha A;
    • Wit, Maurice de;
    • Heer, Iris de;
    • Draaisma, Kaspar;
    • Riet, Job van;
    • Werken, Harmen J G van de;
    • Bours, Vincent;
    • Buter, Jan;
    • Bempt, Isabelle Vanden;
    • Eoli, Marica;
    • Franceschi, Enrico;
    • Frenel, Jean-Sebastien;
    • Gorlia, Thierry;
    • Hanse, Monique C;
    • Hoeben, Ann;
    • Kerkhof, Melissa;
    • Kros, Johan M;
    • Leenstra, Sieger;
    • Lombardi, Giuseppe
    Publication type:
    Article
    17

    Treatment and outcome of intracranial ependymoma after first relapse in the 2nd AIEOP protocol.

    Published in:
    Neuro-Oncology, 2022, v. 24, n. 3, p. 467, doi. 10.1093/neuonc/noab230
    By:
    • Massimino, Maura;
    • Barretta, Francesco;
    • Modena, Piergiorgio;
    • Johann, Pascal;
    • Ferroli, Paolo;
    • Antonelli, Manila;
    • Gandola, Lorenza;
    • Garrè, Maria Luisa;
    • Bertin, Daniele;
    • Mastronuzzi, Angela;
    • Mascarin, Maurizio;
    • Quaglietta, Lucia;
    • Viscardi, Elisabetta;
    • Sardi, Iacopo;
    • Ruggiero, Antonio;
    • Boschetti, Luna;
    • Giagnacovo, Marzia;
    • Biassoni, Veronica;
    • Schiavello, Elisabetta;
    • Chiapparini, Luisa
    Publication type:
    Article
    18
    19
    20

    ELTD1 deletion reduces vascular abnormality and improves T-cell recruitment after PD-1 blockade in glioma.

    Published in:
    Neuro-Oncology, 2022, v. 24, n. 3, p. 398, doi. 10.1093/neuonc/noab181
    By:
    • Huang, Hua;
    • Georganaki, Maria;
    • Conze, Lei Liu;
    • Laviña, Bàrbara;
    • Hooren, Luuk van;
    • Vemuri, Kalyani;
    • van de Walle, Tiarne;
    • Ramachandran, Mohanraj;
    • Zhang, Lei;
    • Pontén, Fredrik;
    • Bergqvist, Michael;
    • Smits, Anja;
    • Betsholtz, Christer;
    • Dejana, Elisabetta;
    • Magnusson, Peetra U;
    • He, Liqun;
    • Lugano, Roberta;
    • Dimberg, Anna
    Publication type:
    Article
    21

    Preclinical modeling in glioblastoma patient-derived xenograft (GBM PDX) xenografts to guide clinical development of lisavanbulin—a novel tumor checkpoint controller targeting microtubules.

    Published in:
    Neuro-Oncology, 2022, v. 24, n. 3, p. 384, doi. 10.1093/neuonc/noab162
    By:
    • Burgenske, Danielle M;
    • Talele, Surabhi;
    • Pokorny, Jenny L;
    • Mladek, Ann C;
    • Bakken, Katrina K;
    • Carlson, Brett L;
    • Schroeder, Mark A;
    • He, Lihong;
    • Hu, Zeng;
    • Gampa, Gautham;
    • Kosel, Matthew L;
    • Decker, Paul A;
    • Kitange, Gaspar J;
    • Schmitt-Hoffmann, Anne;
    • Bachmann, Felix;
    • Vaubel, Rachael A;
    • Eckel-Passow, Jeanette E;
    • Giannini, Caterina;
    • McSheehy, Paul;
    • Lane, Heidi A
    Publication type:
    Article